中創環球(01678.HK)主席向原董事長等索賠2.6億元
中創環球(01678.HK)公布,主席胡明法作原告,向公司原董事長陳芳林、中泰集團及其董事高峰、王樂平、呂濤江、張耀峰索賠2.6億元,及根據高等法院條例第48-49條,法院認為合適的權益。
公司指,胡明法發現陳芳林擅自拿走公司99%左右的資產,中泰集團及其相關高管,如王樂平等可能與陳芳林合謀在2017年半年度報告和全年度的報告中欺騙全體股東及公司,未就股份質押事項作出公告,違反了證監會對許可證持有人的行為準則。而胡明法向公司注資,扮演「白衣騎士」的角色,將公司從清盤呈請中解救出來,為公司的平穩運作、恢復主板上市地位付出了巨大的努力。公司澄清,法律行動是胡明法以個人身份採取的。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.